Solensky Gerald JR 4
4 · Zomedica Pharmaceuticals Corp. · Filed Mar 18, 2019
Insider Transaction Report
Form 4
Solensky Gerald JR
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common Shares, without par value
2019-03-15$1.52/sh+164,473$249,999→ 38,479,882 total - Exercise/Conversion
Stock Option (right to buy)
2019-03-15−164,473→ 1,771,054 totalExercise: $1.52From: 2019-01-10Exp: 2021-01-10→ Common Shares, without par value (164,473 underlying)